CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study

By  

Current Alzheimer Research, Vol. 10, Iss. 7, 2013-09 ,pp. : 742-753

Bentham Science Publishers

Access to resources Recommend Favorite

Randomized, Double-Blind, Placebo-Controlled International Clinical Trial of the AMPAKINE^® CX516 in Elderly Participants with Mild Cognitive Impairment

By Johnson S.A.   Simmon V.F.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 197-200

Humana Press, Inc

Access to resources Recommend Favorite

Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Executive function deficits in persons with mild cognitive impairment: A study with a Tower of London task

By Rainville Constant   Lepage Emilie   Gauthier Serge   Kergoat Marie-Jeanne   Belleville Sylvie  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 34, Iss. 3, 2012-03 ,pp. : 306-324

Routledge Ltd

Access to resources Recommend Favorite